Tasly Pharmaceutical Group Co Ltd (600535) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.044x

Based on the latest financial reports, Tasly Pharmaceutical Group Co Ltd (600535) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥552.13 Million ≈ $80.79 Million USD) by net assets (CN¥12.55 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Tasly Pharmaceutical Group Co Ltd for the company's overall valuation and market capitalisation.

Tasly Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Tasly Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tasly Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tasly Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore 600535 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Aalberts Industries NV AS:AALB	0.047x
Hengan International Group Company Limited F:HGNC	0.066x
StarPower Semiconductor Ltd SHG:603290	0.003x
IAC Inc. NASDAQ:IAC	0.003x
Central Depository Services (India) Limited NSE:CDSL	0.188x
FS KKR Capital Corp NYSE:FSK	-0.002x
XJ Electric Co Ltd SHE:000400	0.059x
PENNON GROUP PLC UNS.ADR2 F:3PN0	N/A

Annual Cash Flow Conversion Efficiency for Tasly Pharmaceutical Group Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. View 600535 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.55 Billion ≈ $1.84 Billion	CN¥1.42 Billion ≈ $208.49 Million	0.114x	-31.74%
2024-12-31	CN¥12.11 Billion ≈ $1.77 Billion	CN¥2.01 Billion ≈ $294.79 Million	0.166x	-18.05%
2023-12-31	CN¥12.69 Billion ≈ $1.86 Billion	CN¥2.58 Billion ≈ $376.90 Million	0.203x	+12.19%
2022-12-31	CN¥12.63 Billion ≈ $1.85 Billion	CN¥2.29 Billion ≈ $334.39 Million	0.181x	-14.01%
2021-12-31	CN¥13.31 Billion ≈ $1.95 Billion	CN¥2.80 Billion ≈ $409.90 Million	0.210x	+45.47%
2020-12-31	CN¥12.38 Billion ≈ $1.81 Billion	CN¥1.79 Billion ≈ $262.10 Million	0.145x	+2.12%
2019-12-31	CN¥11.86 Billion ≈ $1.74 Billion	CN¥1.68 Billion ≈ $245.86 Million	0.142x	+6.27%
2018-12-31	CN¥11.21 Billion ≈ $1.64 Billion	CN¥1.49 Billion ≈ $218.59 Million	0.133x	+245.41%
2017-12-31	CN¥8.97 Billion ≈ $1.31 Billion	CN¥-822.56 Million ≈ $-120.37 Million	-0.092x	-165.20%
2016-12-31	CN¥8.21 Billion ≈ $1.20 Billion	CN¥1.15 Billion ≈ $168.83 Million	0.141x	+218.67%
2015-12-31	CN¥7.71 Billion ≈ $1.13 Billion	CN¥340.00 Million ≈ $49.75 Million	0.044x	-63.75%
2014-12-31	CN¥5.07 Billion ≈ $741.67 Million	CN¥616.76 Million ≈ $90.25 Million	0.122x	+45.65%
2013-12-31	CN¥4.14 Billion ≈ $606.32 Million	CN¥346.17 Million ≈ $50.66 Million	0.084x	-14.97%
2012-12-31	CN¥4.21 Billion ≈ $615.55 Million	CN¥413.31 Million ≈ $60.48 Million	0.098x	+174.55%
2011-12-31	CN¥3.78 Billion ≈ $552.55 Million	CN¥135.14 Million ≈ $19.77 Million	0.036x	-68.97%
2010-12-31	CN¥3.42 Billion ≈ $501.18 Million	CN¥395.05 Million ≈ $57.81 Million	0.115x	-37.45%
2009-12-31	CN¥2.17 Billion ≈ $317.70 Million	CN¥400.39 Million ≈ $58.59 Million	0.184x	+48.33%
2008-12-31	CN¥2.09 Billion ≈ $306.26 Million	CN¥260.21 Million ≈ $38.08 Million	0.124x	+10.81%
2007-12-31	CN¥1.97 Billion ≈ $288.96 Million	CN¥221.55 Million ≈ $32.42 Million	0.112x	+37.29%
2006-12-31	CN¥1.72 Billion ≈ $251.70 Million	CN¥140.56 Million ≈ $20.57 Million	0.082x	-40.49%
2005-12-31	CN¥1.56 Billion ≈ $229.00 Million	CN¥214.90 Million ≈ $31.45 Million	0.137x	-7.13%
2004-12-31	CN¥1.37 Billion ≈ $201.15 Million	CN¥203.27 Million ≈ $29.74 Million	0.148x	+201.11%
2003-12-31	CN¥1.20 Billion ≈ $175.82 Million	CN¥59.00 Million ≈ $8.63 Million	0.049x	-76.26%
2002-12-31	CN¥997.00 Million ≈ $145.89 Million	CN¥206.22 Million ≈ $30.18 Million	0.207x	-38.96%
2001-12-31	CN¥247.20 Million ≈ $36.17 Million	CN¥83.77 Million ≈ $12.26 Million	0.339x	--

About Tasly Pharmaceutical Group Co Ltd

SHG:600535 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.05 Billion

CN¥20.84 Billion CNY

Market Cap Rank

#4912 Global

#836 in China

Share Price

CN¥13.95

Change (1 day)

-0.85%

52-Week Range

CN¥13.23 - CN¥16.16

All Time High

CN¥29.37